Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDConnect Biopharma Holdings Limited Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$1.89 | -$1.89 | -$1.89 |
| Q2 2025 | 2 | -$1.58 | -$1.58 | -$1.58 |
| Q3 2025 | 3 | -$1.77 | -$1.63 | -$1.70 |
| Q4 2025 | 3 | -$2.38 | -$2.08 | -$2.23 |
| Q1 2026 | 1 | -$2.36 | -$2.36 | -$2.36 |
| Q2 2026 | 1 | -$2.43 | -$2.43 | -$2.43 |
| Q3 2026 | 1 | -$2.43 | -$2.43 | -$2.43 |
| Q4 2026 | 1 | -$2.50 | -$2.50 | -$2.50 |
| Q1 2027 | 1 | -$2.96 | -$2.96 | -$2.96 |
| Q2 2027 | 1 | -$3.11 | -$3.11 | -$3.11 |
Connect Biopharma Holdings Limited Earnings Date And Information
Connect Biopharma Holdings Limited last posted its earnings results on Wednesday, August 13th, 2025. The company reported $-0.23 earnings per share for the quarter, missing analysts' consensus estimates of $-0.22 by $0.01. The company had revenue of 48.00 K for the quarter and had revenue of 26.03 M for the year. Connect Biopharma Holdings Limited has generated $0 earnings per share over the last year ($-0.28 diluted earnings per share) and currently has a price-to-earnings ratio of -3.69. Connect Biopharma Holdings Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 26th, 2026 based on prior year's report dates.
Connect Biopharma Holdings Limited Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2025 | Q2 2025 | -$0.22 | -$0.23 | -0.01 | $48.00 K | $48.00 K |
| 03/31/2025 | Q4 2024 | -$0.27 | -$0.42 | -0.15 | $1.91 M | $1.91 M |
| 06/28/2024 | Q2 2024 | N/A | $0.14 | N/A | $1.10 B | $24.12 M |
| 04/16/2024 | Q4 2023 | -$0.03 | -$0.52 | -0.49 | N/A | $0 |
| 06/29/2023 | Q2 2023 | N/A | -$0.56 | N/A | N/A | $0 |
| 04/11/2023 | Q4 2022 | -$3.58 | -$1.03 | 2.55 | N/A | $0 |
| 10/11/2022 | Q2 2022 | N/A | -$13.47 | N/A | N/A | $0 |
| 03/31/2022 | Q4 2021 | -$4.38 | -$1.05 | 3.33 | N/A | $0 |
| 08/31/2021 | Q2 2021 | -$2.36 | -$3.10 | -0.74 | N/A | $0 |
| 12/31/2020 | Q4 2020 | N/A | -$0.00 | N/A | N/A | $0 |
| 06/29/2020 | Q2 2020 | N/A | -$0.00 | N/A | N/A | $0 |
| 12/31/2019 | Q4 2019 | N/A | -$1.51 | N/A | N/A | $0 |
| 06/30/2019 | Q2 2019 | N/A | -$1.51 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Connect Biopharma Holdings Limited Earnings: FAQ's
Connect Biopharma Holdings Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 26th, 2026 based offlast year's report dates.
The conference call for Connect Biopharma Holdings Limited's latest earnings report can be listened to online.
The conference call transcript for Connect Biopharma Holdings Limited's latest earnings report can be read online.
Connect Biopharma Holdings Limited (:CNTB) has a recorded annual revenue of $26.03 M.
Connect Biopharma Holdings Limited (:CNTB) has a recorded net income of $-15,628,000.Connect Biopharma Holdings Limited has generated $-0.28 earnings per share over the last four quarters.
Connect Biopharma Holdings Limited (:CNTB) has a price-to-earnings ratio of -3.69 and price/earnings-to-growth ratio is 0.03.